Abstract:OBJECTIVE The authors analyzed the efficacy of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumors (GCTs) and evaluated the long-term late effects caused by chemoradiotherapy (CRT). METHODS The authors performed a retrospective study. The subjects were 24 patients who received CRT between April 1994 and April 2015. After surgery, intensive chemotherapy followed by reduced-dose and reduced-field irradiation was administered. For those with pure germinoma, who comprised the “good prognosis” group, five courses of conventional-dose chemotherapy (CDC) were administered, and radiotherapy (24 Gy) was applied to the whole ventricle. For all others, defined as the “intermediate and poor prognosis” group, two or three courses of CDC and high-dose chemotherapy were administered with peripheral blood stem cell transplantation and radiotherapy (24–30 Gy) applied to the whole ventricle or a larger field with or without local boost irradiation (20 Gy), which was applied as needed. RESULTS The median period of follow-up was 112.5 months (range 28–261 months), and the 5-/10-year overall and progression-free survival rates were 100%/83.5% and 91.3%/86.5%, respectively. The 5-/10-year overall survival rates determined based on the histological subtypes were 100%/100% for pure germinoma and 93.8%/78.7% for others, respectively. The late toxicities were as follows: endocrine disorder (33% in pure germinoma, 56% in others), involuntary movements (17% in pure germinoma, 39% in others), ear and labyrinth disorders (17% in pure germinoma, 33% in others), and psychiatric disorders (0% in pure germinoma, 33% in others). Nineteen of 24 patients underwent MRI (T2*- or susceptibility-weighted imaging) after radiotherapy, and 16 (84%) of those 19 patients had microbleeds detected, while 2 (10.5%) had radiation-induced cavernous vascular malformations detected. CONCLUSIONS Intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial GCTs had the same outcome as that reported in the literature, but late adverse effects after treatment were observed. Almost all of the complications were relatively mild but had the potential to lead to psychiatric disorders and intracranial hemorrhaging. ABBREVIATIONS AFP = alpha-fetoprotein; CDC = conventional-dose chemotherapy; CMB = cerebral microbleed; CRT = chemoradiotherapy; CSI = craniospinal irradiation; EP = etoposide and cisplatin; GCT = germ cell tumor; HCG = human chorionic gonadotropin; HDC = high-dose chemotherapy; ICE = ifosfamide, cisplatin, and etoposide; NGGCT = nongerminomatous GCT; OS = overall survival; PBSCT = peripheral blood stem cell transplantation; PFS = progression-free survival; RICM = radiation-induced cavernous malformation; STGC = syncytiotrophoblastic giant cell; SWI = susceptibility-weighted imaging.

The early diagnosis and combined treatment with chemotherapy and radiotherapy in intracrinial basal ganglia germinoma: report of 25 cases

Implementation Of Clinical Practice Guidelines For Newly Diagnosed Gbm Patients In China.

Clinical Study of Mailgnant Brain Gliomas Treated by Interstitial Radiotherapy and Interstitial Chemotherapy

[Long-Term Effect of Chemotherapy Combined with Radiotherapy in Treatment of Intracranial Germinoma: Report of 39 Cases].

Initial Clinical and Imaging Characteristics of Basal Ganglia Germinoma in Children

Early diagnosis and comprehensive treatment for germinoma of sellar region

Diagnosis and Treatment of Intracranial Germ Cell Tumors (Clinical Analysis of 38 cases)

Individualized treatment of intracranial germ cell tumors

The clinic follow-up on chemotherapy and radiotherapy of children intracrinial germinoma

Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma

Basal Ganglia Germ Cell Tumors With or Without Sellar Involvement: A Long-Term Follow-Up in a Single Medical Center and a Systematic Literature Review

The Diagnostic Value of CT,MRI and MRS in Primary Basal Ganglia Germinoma

Modified Grading System for Clinical Outcome of Intracranial Non-Germinomatous Malignant Germ Cell Tumors

Conformal intensity modulated radiation therapy for intracranial germinoma and related dosimetry

Epid-36. Clinical Features Of 614 Primary Intracranial Germ Cell Tumors: An 15-Year Experience Of A Single Center In China

Relapse pattern and quality of life in patients with localized basal ganglia germinoma receiving focal radiotherapy, whole-brain radiotherapy, or craniospinal irradiation

Diagnosis and treatment on the intracranial immature teratomas in children ( a report of 36 cases )

Grading System for Diagnosis and Treatment of Intracranial Nongerminomatous Malignant Germ Cell Tumors

Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor

Germinoma of basal ganglia

Diagnosis and Treatment of Intracranial Immature Teratoma.